2021-04-20 |
2021-04-19 |
B
Purchase
|
Cambrian BioPharma Inc
Major owner
|
1,965
+0.0%
13.38
26,292
USD
|
1,965
+0.0%
|
13.38
|
26,292
USD
|
|
2021-04-20 |
2021-04-19 |
B
Purchase
|
Peyer James
Non-Executive Director
Major owner
|
1,965
+0.0%
13.38
26,292
USD
|
1,965
+0.0%
|
13.38
|
26,292
USD
|
|
2021-04-14 |
2021-04-13 |
B
Purchase
|
Cambrian BioPharma Inc
Major owner
|
2,000
+0.0%
14.00
28,000
USD
|
2,000
+0.0%
|
14.00
|
28,000
USD
|
|
2021-04-14 |
2021-04-13 |
B
Purchase
|
Peyer James
Non-Executive Director
Major owner
|
2,000
+0.0%
14.00
28,000
USD
|
2,000
+0.0%
|
14.00
|
28,000
USD
|
|
2021-04-08 |
2021-04-07 |
B
Purchase
|
Peyer James
Non-Executive Director
Major owner
|
2,000
+0.0%
14.00
28,000
USD
|
2,000
+0.0%
|
14.00
|
28,000
USD
|
|
2021-04-02 |
2021-04-01 |
B
Purchase
|
Peyer James
Non-Executive Director
Major owner
|
1,000
+0.0%
14.00
14,000
USD
|
1,000
+0.0%
|
14.00
|
14,000
USD
|
|
2021-04-02 |
2021-04-01 |
B
Purchase
|
Cambrian BioPharma Inc
Major owner
|
1,000
+0.0%
14.00
14,000
USD
|
1,000
+0.0%
|
14.00
|
14,000
USD
|
|
2021-03-25 |
2021-03-24 |
B
Purchase
|
Peyer James
Non-Executive Director
Major owner
|
3,750
+0.1%
14.12
52,950
USD
|
3,750
+0.1%
|
14.12
|
52,950
USD
|
|
2021-03-25 |
2021-03-24 |
B
Purchase
|
Cambrian BioPharma Inc
Major owner
|
3,750
+0.1%
14.12
52,950
USD
|
3,750
+0.1%
|
14.12
|
52,950
USD
|
|
2021-03-24 |
2021-03-23 |
B
Purchase
|
Cambrian BioPharma Inc
Major owner
|
10,000
+0.2%
14.34
143,400
USD
|
10,000
+0.2%
|
14.34
|
143,400
USD
|
|
2021-03-24 |
2021-03-23 |
B
Purchase
|
Peyer James
Non-Executive Director
Major owner
|
10,000
+0.2%
14.34
143,400
USD
|
10,000
+0.2%
|
14.34
|
143,400
USD
|
|
2021-03-23 |
2021-03-22 |
B
Purchase
|
Peyer James
Non-Executive Director
Major owner
|
2,183
+0.0%
15.02
32,789
USD
|
2,183
+0.0%
|
15.02
|
32,789
USD
|
|
2021-03-23 |
2021-03-22 |
B
Purchase
|
Cambrian BioPharma Inc
Major owner
|
2,183
+0.0%
15.02
32,789
USD
|
2,183
+0.0%
|
15.02
|
32,789
USD
|
|
2021-03-19 |
2021-03-18 |
B
Purchase
|
Cambrian BioPharma Inc
Major owner
|
817
+0.0%
15.25
12,459
USD
|
817
+0.0%
|
15.25
|
12,459
USD
|
|
2021-03-19 |
2021-03-18 |
B
Purchase
|
Peyer James
Non-Executive Director
Major owner
|
817
+0.0%
15.25
12,459
USD
|
817
+0.0%
|
15.25
|
12,459
USD
|
|
2021-03-10 |
2021-03-08 |
B
Purchase
|
Peyer James
Non-Executive Director
Major owner
|
1,000
+0.0%
15.25
15,249
USD
|
1,000
+0.0%
|
15.25
|
15,249
USD
|
|
2021-03-10 |
2021-03-08 |
B
Purchase
|
Cambrian BioPharma Inc
Major owner
|
1,000
+0.0%
15.25
15,249
USD
|
1,000
+0.0%
|
15.25
|
15,249
USD
|
|
2021-03-08 |
2021-03-05 |
B
Purchase
|
Cambrian BioPharma Inc
Major owner
|
8,000
+0.2%
13.75
110,000
USD
|
8,000
+0.2%
|
13.75
|
110,000
USD
|
|
2021-03-08 |
2021-03-05 |
B
Purchase
|
Peyer James
Non-Executive Director
Major owner
|
8,000
+0.2%
13.75
110,000
USD
|
8,000
+0.2%
|
13.75
|
110,000
USD
|
|
2021-03-05 |
2021-03-04 |
B
Purchase
|
Peyer James
Non-Executive Director
Major owner
|
2,000
+0.0%
14.13
28,250
USD
|
2,000
+0.0%
|
14.13
|
28,250
USD
|
|
2021-03-05 |
2021-03-04 |
B
Purchase
|
Cambrian BioPharma Inc
Major owner
|
2,000
+0.0%
14.13
28,250
USD
|
2,000
+0.0%
|
14.13
|
28,250
USD
|
|
2021-03-05 |
2021-03-03 |
B
Purchase
|
Peyer James
Non-Executive Director
Major owner
|
3,000
+0.1%
15.85
47,550
USD
|
3,000
+0.1%
|
15.85
|
47,550
USD
|
|
2021-03-05 |
2021-03-03 |
B
Purchase
|
Cambrian BioPharma Inc
Major owner
|
3,000
+0.1%
15.85
47,550
USD
|
3,000
+0.1%
|
15.85
|
47,550
USD
|
|
2021-03-03 |
2021-03-02 |
B
Purchase
|
Peyer James
Non-Executive Director
Major owner
|
3,000
+0.1%
16.25
48,750
USD
|
3,000
+0.1%
|
16.25
|
48,750
USD
|
|
2021-03-03 |
2021-03-02 |
B
Purchase
|
Cambrian BioPharma Inc
Major owner
|
3,000
+0.1%
16.25
48,750
USD
|
3,000
+0.1%
|
16.25
|
48,750
USD
|
|
2021-03-02 |
2021-02-26 |
B
Purchase
|
Cambrian BioPharma Inc
Major owner
|
5,000
+0.1%
16.25
81,250
USD
|
5,000
+0.1%
|
16.25
|
81,250
USD
|
|
2021-03-02 |
2021-02-26 |
B
Purchase
|
Peyer James
Non-Executive Director
Major owner
|
5,000
+0.1%
16.25
81,250
USD
|
5,000
+0.1%
|
16.25
|
81,250
USD
|
|
2021-02-26 |
2021-02-25 |
B
Purchase
|
Peyer James
Non-Executive Director
Major owner
|
12,000
+0.3%
15.79
189,480
USD
|
12,000
+0.3%
|
15.79
|
189,480
USD
|
|
2021-02-26 |
2021-02-25 |
B
Purchase
|
Cambrian BioPharma Inc
Major owner
|
12,000
+0.3%
15.79
189,480
USD
|
12,000
+0.3%
|
15.79
|
189,480
USD
|
|
2021-02-26 |
2021-02-24 |
B
Purchase
|
Peyer James
Non-Executive Director
Major owner
|
900
+0.0%
18.42
16,578
USD
|
900
+0.0%
|
18.42
|
16,578
USD
|
|
2021-02-26 |
2021-02-24 |
B
Purchase
|
Cambrian BioPharma Inc
Major owner
|
900
+0.0%
18.42
16,578
USD
|
900
+0.0%
|
18.42
|
16,578
USD
|
|
2021-02-26 |
2021-02-24 |
B
Purchase
|
Peyer James
Non-Executive Director
Major owner
|
18,100
+0.4%
16.84
304,804
USD
|
18,100
+0.4%
|
16.84
|
304,804
USD
|
|
2021-02-26 |
2021-02-24 |
B
Purchase
|
Cambrian BioPharma Inc
Major owner
|
18,100
+0.4%
16.84
304,804
USD
|
18,100
+0.4%
|
16.84
|
304,804
USD
|
|
2021-02-25 |
2021-02-23 |
B
Purchase
|
Cambrian BioPharma Inc
Major owner
|
14,300
+0.3%
18.10
258,830
USD
|
14,300
+0.3%
|
18.10
|
258,830
USD
|
|
2021-02-25 |
2021-02-23 |
B
Purchase
|
Peyer James
Non-Executive Director
Major owner
|
14,300
+0.3%
18.10
258,830
USD
|
14,300
+0.3%
|
18.10
|
258,830
USD
|
|
2021-02-25 |
2021-02-23 |
B
Purchase
|
Cambrian BioPharma Inc
Major owner
|
6,000
+0.1%
17.04
102,240
USD
|
6,000
+0.1%
|
17.04
|
102,240
USD
|
|
2021-02-25 |
2021-02-23 |
B
Purchase
|
Peyer James
Non-Executive Director
Major owner
|
6,000
+0.1%
17.04
102,240
USD
|
6,000
+0.1%
|
17.04
|
102,240
USD
|
|
2021-02-24 |
2021-02-22 |
B
Purchase
|
Cambrian BioPharma Inc
Major owner
|
9,802
+0.2%
18.88
185,062
USD
|
9,802
+0.2%
|
18.88
|
185,062
USD
|
|
2021-02-24 |
2021-02-22 |
B
Purchase
|
Peyer James
Non-Executive Director
Major owner
|
9,802
+0.2%
18.88
185,062
USD
|
9,802
+0.2%
|
18.88
|
185,062
USD
|
|
2021-02-23 |
2021-02-19 |
B
Purchase
|
Cambrian BioPharma Inc
Major owner
|
11,786
+0.3%
19.77
233,009
USD
|
11,786
+0.3%
|
19.77
|
233,009
USD
|
|
2021-02-23 |
2021-02-19 |
B
Purchase
|
Peyer James
Non-Executive Director
Major owner
|
11,786
+0.3%
19.77
233,009
USD
|
11,786
+0.3%
|
19.77
|
233,009
USD
|
|
2021-02-19 |
2021-02-18 |
B
Purchase
|
Cambrian BioPharma Inc
Major owner
|
753
+0.0%
19.75
14,872
USD
|
753
+0.0%
|
19.75
|
14,872
USD
|
|
2021-02-19 |
2021-02-18 |
B
Purchase
|
Peyer James
Non-Executive Director
Major owner
|
753
+0.0%
19.75
14,872
USD
|
753
+0.0%
|
19.75
|
14,872
USD
|
|